NCT06664021 2025-01-10
Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the Treatment of Patients With Postoperative Recurrent High-risk Intrahepatic Cholangiocarcinoma
Anhui Provincial Hospital
Phase 2 Recruiting
Clinical Trials
5 trialsNCT05207735 2022-01-26
SCRCA
Henan Cancer Hospital
Phase 2 Unknown
NCT01043172 2018-01-03
A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection
National Cancer Center, Korea
Phase 2 Completed
NCT01525719 2012-02-03
CRAD001T
Ratchavithi Hospital
Phase 2 Unknown
NCT00973713 2009-09-09
RADiChol
Austin Health
Phase 2 Unknown